News

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer
2025年1月17日
SHANGHAI, January 16th, 2025 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
2025年1月13日
[January 13, 2025] – Cornerstone Robotics (the “Company”), a leading global innovator in surgical...
Alebund Pharmaceutical announced the first closing of RMB 550 million in Series C financing
2025年1月7日
January 7, 2025, Alebund Pharmaceuticals (“Alebund” or the “Company”), an integrated...
More Posts

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES